The patients in the clinical series as well as in the group with preoperative known cardiac risk receiving postoperative ASA medication yielded a significant better long-term survival results. ASA prolongs long-term survival after carotid endarterectomy. A postoperative ASA-therapy decreases the incidence of lethal cardiac complications.